干燥設備 粉碎設備 混合設備 反應設備 過濾分離設備 過濾材料 滅菌設備 萃取設備 貯存設備 傳熱設備 鍋爐 塔設備 結晶設備 其它制藥設備
賽默飛世爾科技(中國)有限公司
| 參 考 價 | 面議 |
產(chǎn)品型號Gibco
品 牌
廠商性質(zhì)生產(chǎn)商
所 在 地
聯(lián)系方式:Tracy查看聯(lián)系方式
更新時間:2024-08-11 08:44:22瀏覽次數(shù):406次
聯(lián)系我時,請告知來自 制藥網(wǎng)暫無信息 |
CTS™ OpTmizer™ T-Cell Expansion SFM, no phenol red
Gibco CTS OpTmizer T-Cell Expansion SFM supports the growth and expansion of human T lymphocytes. It is a complete serum-free, xeno-free medium consisting of CTS OpTmizer T-Cell Expansion Basal Medium and CTS OpTmizer T-Cell Expansion Supplement, which are mixed together prior to use.
CTS OpTmizer T-Cell Expansion SFM in 5 L and 10 L bag format is compatible with closed-system processing for media preparation. 5 L and 10 L volumes support scaling of cell therapy manufacturing workflows. The updated bag format allows for easier integration with standard cell therapy equipment, including CTS devices (Xenon, Rotea, and DynaCellect).
Features of CTS OpTmizer T-Cell Expansion SFM include:
• Both kit components (medium and supplement) in Aegis5-14 film bags
• Weldable C-Flex and PVC lines
• Supports high-density T-cell culture (>4 x 106 CD3+ T cells/mL)
• Supports T-cell activation using Dynabeads magnetic beads, soluble antibodies, and stimulatory antibody-presenting cell protocols
• Similar phenotype, function (e.g., cytokine secretion profile), and viability to T cells cultured with conventional human AB serum–supplemented medium
• Supports a T-cell phenotype similar to human serum–supplemented medium
• Demonstrates enhanced efficacy and persistence of CART-19 cells when grown in medium supplemented with CTS Immune Cell Serum Replacement (ICSR)
Benefits include:
• Prepare complete medium in a closed system with weldable lines
• Reduces open steps and contamination risks
• Easy integration with CTS automated instrumentation
Demonstrated functional performance
Cells grown in CTS OpTmizer T-Cell Expansion SFM with or without human serum demonstrate good cytokine production profiles in polyclonally activated T cells. CTS OpTmizer T-Cell Expansion SFM maintains the desired the CD62L+ central memory T-cell phenotype.
GMP manufactured
The primary manufacturing site for CTS OpTmizer T-Cell Expansion SFM is FDA-registered and has an ISO13485–certified quality management system. The methods and controls used for the manufacturing are in conformity with current Good Manufacturing Practices for medical devices, 21 CFR Part 820, of the regulation.
Versatility
CTS OpTmizer T-Cell Expansion SFM has been widely adopted in clinical T-cell research applications including the culture of CAR T-cells. It works with multiple culture formats: culture flasks, culture bags, and automated and scalable bioreactors. CTS OpTmizer T-Cell Expansion SFM was designed to support expansion of cultured human T-cells without additional serum supplementation. Increased performance is generally observed when supplemented with CTS Immune Cell Serum Replacement.
您感興趣的產(chǎn)品PRODUCTS YOU ARE INTERESTED IN
制藥網(wǎng) 設計制作,未經(jīng)允許翻錄必究 .? ? ?
請輸入賬號
請輸入密碼
請輸驗證碼
請輸入你感興趣的產(chǎn)品
請簡單描述您的需求
號碼可能有誤,請核對!
請選擇省份
聯(lián)系方式
賽默飛世爾科技(中國)有限公司
定安县|
祁东县|
汉川市|
得荣县|
托克托县|
墨竹工卡县|
施秉县|
永新县|
金川县|
乌什县|
锡林郭勒盟|
军事|
紫阳县|
深泽县|
聂荣县|
天门市|
安陆市|
方城县|
霞浦县|
扶余县|
壶关县|
岢岚县|
南涧|
张家川|
周口市|
白城市|
哈尔滨市|
镇宁|
墨江|
桃源县|
上饶市|
哈巴河县|
长顺县|
涿鹿县|
黔江区|
灌南县|
三江|
会宁县|
鹤峰县|
霍城县|
台南市|
